DF/HCC Program Affiliation

Breast Cancer
Outcomes Research

Research Abstract

Dr. Partridge's research focuses on doctor-patient communication, risk perceptions, and behavioral issues surrounding the diagnosis and treatment of women with breast cancer. Current projects include studying adherence with oral antineoplastic agents in breast cancer patients, communication issues surrounding clinical trials, decision-making and risk communication in women with ductal carcinoma-in-situ (DCIS), and fertility concerns in young women with breast cancer.

Publications

• Tolaney SM, Partridge AH, Sheib RG, Burstein HJ, Winer EP.Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.J Clin Oncol 2006 Nov 20;24(33):5330-1.
  17114668
• Leining MG, Gelber S, Rosenberg R, Przypyszny M, Winer EP, Partridge AH.Menopausal-type symptoms in young breast cancer survivors.Ann Oncol 2006 Dec;17(12):1777-82.
  16971671
• Burstein HJ, Mayer E, Patridge AH, O'Kane H, Litsas G, Come SE, Hudis CA, Goldstein DF, Muss HB, Winter EP, Garber JE.Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons.Clin Breast Canc
  16800976
• , Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K.American Society of Clinical Oncology recommendations on fertility preservation in cancer patients.J Clin Oncol 2006 Jun 20;24(18):2917-31.
  16651642
• Simon B, Lee SJ, Partridge AH, Runowicz CD.Preserving fertility after cancer.CA Cancer J Clin 2005 Jul-Aug;55(4):211-28; quiz 263-4.
  16020423
• Partridge A, Schapira L.Pregnancy and breast cancer: epidemiology, treatment, and safety issues.Oncology (Huntingt) 2005 May;19(6):693-7; discussion 697-700.
  15971447
• Partridge AH, Hackett N, Blood E, Gelman R, Joffe S, Bauer-Wu S, Knudsen K, Emmons K, Collyar D, Schilsky RL, Winer EP.Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants.J Natl Cancer Inst
  15100341
• Partridge AH, Winer EP, Burstein HJ.Follow-up care of breast cancer survivors.Semin Oncol 2003 Dec;30(6):817-25.
  14663782
• Nekhlyudov L, Partridge A.Breast cancer risk communication: challenges and future research directions: workshop report (United States).Cancer Causes Control 2003 Apr;14(3):235-9.
  12814202
• Partridge AH, Burstein HJ, Gelman RS, Marcom PK, Winer EP.Do patients participating in clinical trials want to know study results?.J Natl Cancer Inst 2003 Mar 19;95(6):491-2.
  12644548
• Partridge AH, Wang PS, Winer EP, Avorn J.Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.J Clin Oncol 2003 Feb 15;21(4):602-6.
  12586795
• Partridge AH, Winer EP.Informing clinical trial participants about study results.JAMA 2002 Jul 17;288(3):363-5.
  12117402
• Partridge AH, Avorn J, Wang PS, Winer EP.Adherence to therapy with oral antineoplastic agents.J Natl Cancer Inst 2002 May 1;94(9):652-61.
  11983753
• Burstein HJ, Partridge AH, Lesnikoski BA.Treatment of breast cancer during pregnancy.Expert Opin Pharmacother 2002 Apr;3(4):423-8.
  11934346